Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

RIVN Stock Alert: Why Rivian Is Down Today

By Josh Enomoto, InvestorPlace Contributor

With Rivian Automotive about to enter a sector price war, even a credit agreement might not be enough to help RIVN stock.

BuzzFeed Layoffs 2023: What to Know About the Latest BZFD Job Cuts

By Josh Enomoto, InvestorPlace Contributor

Despite best efforts to stay relevant, BuzzFeed struggled against a digital ad market decline, resulting in today's BuzzFeed layoffs.

7 Small-Cap Stocks With Big Potential

By Josh Enomoto, InvestorPlace Contributor

If you want to have a shot at significant upside potential, you may want to consider these relevant small-cap stocks to buy.

7 Short-Squeeze Stocks That Are Breaking All the Rules

By Josh Enomoto, InvestorPlace Contributor

Although the bears have every reason to cynically target these troubled enterprises, they vexingly represent short-squeeze stocks.

The Greatest 7 Blue-Chip Stocks to Buy for Your Portfolio

By Josh Enomoto, InvestorPlace Contributor

With so many rumblings in the equities space, investors may be best served taking on the top blue-chip stocks to buy.

7 Low-PE Ratio Blue-Chip Stocks Offering Both Quality and Value

By Josh Enomoto, InvestorPlace Contributor

Make your dollars go as far as possible (and relatively safely) with these low-PE ratio blue-chip stocks to buy.

7 Biotech Stocks That Could Cure Your Portfolio Woes

By Josh Enomoto, InvestorPlace Contributor

If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill.

7 Companies That Could Benefit from the Rise of Artificial Intelligence

By Josh Enomoto, InvestorPlace Contributor

With so companies pouring billions into artificial intelligence, investors should consider bidding up the top AI leaders.

Opendoor Layoffs 2023: What to Know About the Latest OPEN Job Cuts

By Josh Enomoto, InvestorPlace Contributor

Opendoor just announced layoffs to make room for potential opportunities, but the economic backdrop for OPEN stock looks poor.

Why Are EV Stocks TSLA, NIO, XPEV, RIVN Down Today?

By Josh Enomoto, InvestorPlace Contributor

With slumping demand sparking a rise of competitiveness for consumer dollars, EV stocks are facing pressure from pricing wars.

Load More